Literature DB >> 6084425

New immunocytochemical observations with diagnostic significance in cutaneous neuroendocrine carcinoma.

H Hoefler, H Kerl, H J Rauch, H Denk.   

Abstract

The presence and distribution of cytokeratins, actin, neurofilament protein, neuron-specific enolase, S-100 protein, and different neuropeptides were studied immunohistochemically by the peroxidase-antiperoxidase immunoenzyme method or the avidin-biotin-peroxidase technique in 10 patients with primary cutaneous neuroendocrine carcinoma. In all cases of cutaneous neuroendocrine carcinoma, immunoreactivity for neuron-specific enolase, cytokeratin, and neurofilament was identified. No staining was found after incubation with antibodies to S-100 protein, actin, and other tested neuropeptides. The cytoplasmic cytokeratin and neurofilament immunoreactivity was particularly strong in perinuclear areas, sometimes showing an annular pattern or displaying a discoid profile. The diagnosis of cutaneous neuroendocrine carcinoma may be reliably made by the immunocytochemical demonstration of neuron-specific enolase and intermediate filaments (cytokeratin, neurofilament protein) by conventional microscopy. Cutaneous neuroendocrine carcinoma has morphological, immunological, and histogenetic similarities to carcinoid neoplasms of the gut. We favor the concept that cutaneous neuroendocrine carcinoma is derived from, or differentiates toward, dermal neuroendocrine cells.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6084425     DOI: 10.1097/00000372-198412000-00002

Source DB:  PubMed          Journal:  Am J Dermatopathol        ISSN: 0193-1091            Impact factor:   1.533


  13 in total

1.  Merkel cell carcinoma of the head and neck associated with Bowen's disease.

Authors:  P Schenk; K Konrad
Journal:  Eur Arch Otorhinolaryngol       Date:  1991       Impact factor: 2.503

2.  Immunocytochemical demonstration of intermediate filament cytoskeleton proteins in human endocrine tissues and (neuro-) endocrine tumours.

Authors:  H Hoefler; H Denk; E Lackinger; G Helleis; J M Polak; P U Heitz
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1986

3.  (68)Ga-DotaTATE PET-CT followed by Peptide Receptor Radiotherapy in combination with capecitabine in two patients with Merkel Cell Carcinoma.

Authors:  Matthias C Schmidt; Klara Uhrhan; Birgid Markiefka; Laura Hasselbring; Max Schlaak; Birgit Cremer; Sabine Kunze; Richard P Baum; Markus Dietlein
Journal:  Int J Clin Exp Med       Date:  2012-09-28

4.  Human lung tumours may coexpress different classes of intermediate filaments.

Authors:  K C Gatter; M S Dunnill; G N Van Muijen; D Y Mason
Journal:  J Clin Pathol       Date:  1986-09       Impact factor: 3.411

5.  Cytokeratin 20 in human carcinomas. A new histodiagnostic marker detected by monoclonal antibodies.

Authors:  R Moll; A Löwe; J Laufer; W W Franke
Journal:  Am J Pathol       Date:  1992-02       Impact factor: 4.307

Review 6.  Neuroendocrine (Merkel cell) carcinoma of the skin. Its natural history, diagnosis, and treatment.

Authors:  C L Hitchcock; K I Bland; R G Laney; D Franzini; B Harris; E M Copeland
Journal:  Ann Surg       Date:  1988-02       Impact factor: 12.969

7.  The intermediate filament cytoskeleton of cutaneous neuroendocrine carcinoma (Merkel cell tumour). Immunohistochemical and biochemical analyses.

Authors:  H Höfler; H Kerl; E Lackinger; G Helleis; H Denk
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1985

8.  Immunocytochemical analysis of Ewing's tumors. Patterns of expression of intermediate filaments and desmosomal proteins indicate cell type heterogeneity and pluripotential differentiation.

Authors:  R Moll; I Lee; V E Gould; R Berndt; A Roessner; W W Franke
Journal:  Am J Pathol       Date:  1987-05       Impact factor: 4.307

9.  Immunohistochemical demonstration of cytokeratins in endocrine cells of the human pituitary gland and in pituitary adenomas.

Authors:  H Höfler; H Denk; G F Walter
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1984

10.  Which are the cells of origin in merkel cell carcinoma?

Authors:  Thomas Tilling; Ingrid Moll
Journal:  J Skin Cancer       Date:  2012-12-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.